The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEco Animal Regulatory News (EAH)

Share Price Information for Eco Animal (EAH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 112.50
Bid: 110.00
Ask: 115.00
Change: 0.00 (0.00%)
Spread: 5.00 (4.545%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 112.50
EAH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate change

19 Aug 2019 07:00

 

ECO Animal Health Group plc (‘’ECO”)

(AIM: EAH)

Directorate Changes

ECO Animal Health Group plc (the “Group”) is pleased to announce the appointment of Christopher Wilks as Chief Financial Officer of ECO from 3 September 2019. Christopher Wilks has considerable experience in the fields of both finance and science. He is currently a non-executive director of Kromek Group plc, an AIM listed worldwide supplier of detection technology and was previously Chief Financial Officer of Signum Technology, a leading group of specialised engineering businesses operating in the safety and critical service flow control sector, which he co-founded in 2012. Prior to Signum Technology, Mr Wilks was Chief Financial Officer at Sondex plc, a specialist manufacturer of technical instruments for the oil and gas industry. Mr Wilks became the Chief Financial Officer of Sondex in 1997 and in June 2003 he successfully managed the listing of Sondex plc on the Main Market of the London Stock Exchange. Sondex was acquired by GE in 2007.

Mr Wilks began his successful career after graduating from the University of Durham with a BSc in Applied Physics and Electronics. Initially he joined Marconi Space Systems, applying his degree skills to the design of power systems for spacecraft. He then trained as a Chartered Accountant at Ernst & Young (now EY), and after qualifying as a Chartered Accountant in audit, he became a manager of its Corporate Finance team.

Kevin Stockdale, Financial Director, has resigned from the Board and shall remain with the Company.

Julia Trouse, Executive Director, has resigned from the Board and shall remain as Company Secretary in order to comply with QCA guidelines.

Brett Clemo, Executive Director, had informed the Board of his intention to retire in 2017 and will start his long planned for retirement on the 30th September 2019. He will not stand for re-election at the Company's Annual General Meeting scheduled to take place on 19 September 2019.

Following these board changes the board will comprise three independent non-executive directors being Richard Wood (Chairman), Andrew Jones and Tony Rawlinson and two executive directors being Marc Loomes (CEO) and Christopher Wilks (CFO), thereby fulfilling one of its Corporate Governance objectives stated in its 2019 Annual Report and Accounts Corporate Governance Statement of establishing an Independent Board with a majority of non-executive directors.

Marc Loomes, CEO of ECO, commented:

“I'm delighted to welcome Chris to our Board as CFO. He brings a wealth of experience, having successfully grown listed businesses, and is a great addition to our management team as we look to build on our momentum. I would like to take this opportunity to extend my sincere thanks to Kevin and Julia for the considerable contributions that they have made to the Board over many years. The Board would like to thank Brett for his invaluable contribution to the growth and development of ECO over the past 13 years and to wish him all the very best for his retirement.”

AIM disclosures

Christopher John Wilks is 55 years old and during the last five years immediately preceding the date of this announcement held the following directorships:

 

Current directorships

Previous directorships

Kromek Group plc

Copper Bidco Ltd

 

Copper Midco 1 Ltd

 

Copper Midco 2 Ltd

 

Falcon Oilfield Services LLC

 

Filtration and Valves Ltd

 

Gall Thomson Environmental Ltd

 

Gall Thomson International Ltd

 

Klaw Products Ltd

 

Signum Technology Ltd

 

Vee Bee Filtration (UK) Ltd

 

Vee Bee Ltd

Mr Wilks was a director of Clearwater Industries between 1994 and 1996. In 1996, Clearwater Industries was put into liquidation and was sold two days later. The creditor shortfall was approximately £100,000.

There is no further information to be disclosed pursuant to Schedule Two Part (g) of the AIM Rules for Companies.

Enquiries:

ECO Animal Health Group plc

Richard Wood, Chairman

Marc Loomes, CEO

 

020 8447 6906

IFC Advisory

Graham Herring

Miles Nolan

 

 

020 3934 6637

N+1 Singer (Nominated Adviser & Joint Broker)

Mark Taylor

Alex Bond

 

020 7496 3000

Peel Hunt LLP (Joint Broker)

James Steel

Dr Christopher Golden

020 7418 8900

About ECO Animal Health Ltd

ECO Animal Health based in London U.K. is a leader in the development, registration and marketing of pharmaceutical products for global animal health markets. Its products for these growth markets promote well-being in animals and include the novel antimicrobial, Aivlosin®, as well as a range of generic therapeutic products.

View source version on businesswire.com: https://www.businesswire.com/news/home/20190818005008/en/

Copyright Business Wire 2019

Date   Source Headline
25th Apr 20247:00 amRNSTrading Update on year ended 31 March 2024
8th Apr 20247:00 amRNSHolding(s) in Company
4th Apr 20247:00 amRNSDisposal of non-core product line
22nd Mar 20247:00 amRNSShare Awards to Executive Directors
21st Mar 20249:13 amRNSReplacement: Trading Update
21st Mar 20247:00 amRNSTrading Update
19th Mar 20249:40 amRNSGeneral Meeting Result
27th Feb 20247:00 amRNSPublication of Notice of General Meeting
6th Feb 20247:00 amRNSTrademark Approval for ECOVAXXIN® family in the EU
8th Jan 20247:00 amRNSDisposal of Freehold Properties
5th Jan 20245:05 pmRNSHolding(s) in Company
5th Jan 20245:00 pmRNSHolding(s) in Company
22nd Dec 20237:00 amRNSDeferred Option Awards to Executive Directors
1st Dec 20237:00 amRNSDirector/PDMR Shareholding
27th Nov 202310:00 amRNSInvestor Presentation
27th Nov 20237:00 amRNSResults for the six months ended 30 September 2023
14th Nov 20233:00 pmRNSHolding(s) in Company
9th Nov 20237:00 amRNSCapital Markets Day Events
24th Oct 20237:00 amRNSNew USA and Canada label claim for Aivlosin®
28th Sep 20237:00 amRNSESG Rating
7th Sep 20232:57 pmRNSResult of AGM
10th Aug 20237:00 amRNSNotice of AGM
21st Jul 20234:25 pmRNSPosting of the Annual Report and Accounts
10th Jul 20237:00 amRNSFinal Results for the Year Ended 31 March 2023
5th Jul 20237:00 amRNSNotice of Results & Investor Presentation
6th Jun 20237:00 amRNSIssue of Equity and Total Voting Rights
18th May 20237:00 amRNSHolding(s) in Company
23rd Mar 20237:00 amRNSTrading Update
8th Mar 20237:00 amRNSAnimal Health Innovation Summit
27th Feb 202310:37 amRNSDirector/PDMR Shareholding
24th Feb 20233:19 pmRNSChange of Registered Address
17th Feb 20231:41 pmRNSHolding(s) in Company
13th Feb 20231:55 pmRNSHolding(s) in Company
9th Feb 20237:00 amRNSHolding(s) in Company
9th Feb 20237:00 amRNSHolding(s) in Company
8th Feb 20237:00 amRNSDirector/PDMR Shareholding
20th Jan 202312:14 pmRNSHolding(s) in Company
13th Dec 20223:50 pmRNSDeferred Share Option Awards
30th Nov 20223:01 pmRNSDirector/PDMR Shareholding
25th Nov 20221:37 pmRNSDirector/PDMR Shareholding
23rd Nov 20227:00 amRNSResults for the six months ended 30 September 2022
22nd Nov 20227:00 amRNSInvestor Presentation covering Interim Results
14th Nov 20227:00 amRNSChange of Auditor
31st Oct 20227:00 amRNSBlock listing Interim Review
24th Oct 20221:30 pmRNSHolding(s) in Company
24th Oct 20221:28 pmRNSHolding(s) in Company
26th Sep 20224:01 pmRNSResult of AGM
5th Sep 20221:00 pmRNSInvestor Presentation covering Full Year Results
2nd Sep 20227:00 amRNSPublication of Annual Report and Notice of AGM
31st Aug 20227:00 amRNSFinal Results for the Year Ended 31 March 2022

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.